ライフサイエンスコーパス: pharmacy

1 y Compounding Accreditation Board-accredited pharmacy).

2 ndles larger quantities of the drug (e.g., a pharmacy).

3 ion, leading to antibiotic collection from a pharmacy.

4 applications in the fields of chemistry and pharmacy.

5 and may vary dramatically, depending on the pharmacy.

6 on between samples from the same compounding pharmacy.

7 ients receiving PN from a single compounding pharmacy.

8 mcinolone obtained from a single compounding pharmacy.

9 uating pharmacy students at 12 US schools of pharmacy.

10 r studying life processes in biomedicine and pharmacy.

11 1 year from 1 lot prepared by a compounding pharmacy.

12 mcinolone obtained from a single compounding pharmacy.

13 late in picking up their medication from the pharmacy.

14 that was purchased from a single compounding pharmacy.

15 ening and management programs offered in the pharmacy.

16 fection (URTI), which were presented at each pharmacy.

17 repared in insulin syringes by a compounding pharmacy.

18 8 patients who received regorafenib from our pharmacy.

19 ) antiretroviral therapy (ART) via community pharmacies.

20 mation on all prescriptions filled in Danish pharmacies.

21 heduled to present each case once to sampled pharmacies.

22 eceive prescription-only drugs directly from pharmacies.

23 a randomized trial conducted in 56 community pharmacies.

24 10% of antibiotics dispensed in UK community pharmacies.

25 btain emergency contraception from community pharmacies.

26 ns dispensed during 2008 by 76% of US retail pharmacies.

27 CLIA-waived POCT-based programs in community pharmacies.

28 es, and from 0.16 million to 0.13 million at pharmacies.

29 simulated interactions within 2411 community pharmacies.

30 es, and from 0.14 million to 0.13 million at pharmacies.

31 stores, and from 6.76 cents to 6.93 cents at pharmacies.

32 ame drugs were modest across types of retail pharmacies.

33 rice matching that may be offered by smaller pharmacies.

34 mpared with a reference group of large chain pharmacies.

35 stores, and from 6.60 cents to 8.28 cents at pharmacies.

36 s (95% CI, 1.50 cents-1.62 cents; P<.001) at pharmacies.

37 6-0.78], p<0.0001) and being part of a chain pharmacy (0.75 [0.62-0.89], p=0.0012).

38 ations (1.31 cent/oz, p = 0.004), partial in pharmacies (+0.45 cent/oz, p = 0.03), and negative in in

39 nded samples of bevacizumab obtained from 11 pharmacies, 17 (81%) had lower protein concentrations (m

40 without insurance, price compare at multiple pharmacies; (3) use manufacturer-supplied coupons to red

41 r medical ($2684 vs $1980; P < .0001), lower pharmacy ($807 vs $1467; P < .0001), and greater overall

42 (including antibiotic stewardship), nursing, pharmacy, a patient advocate and a CPG methodologist.

43 (including antibiotic stewardship), nursing, pharmacy, a patient advocate, and a CPG methodologist.

44 illustrates the use of CAR-T cells as "micro-pharmacies" able to deliver an anti-cancer protein.

45 9 public, semiprivate (Karunya), and private pharmacies across 5 districts in Kerala using World Heal

46 re recruited in 2012-13 from community-based pharmacies across Australia.

47 Pharmacies across the country have been incorporating CL

48 ochemistry, molecular materials, biology and pharmacy, although it is certainly in coordination chemi

49 cluster-randomised crossover trial in 29 UK pharmacies among women receiving levonorgestrel emergenc

50 tely compounded dry powder) and a variety of pharmacies (an academic hospital, a community hospital,

51 Compared with large chains, independent pharmacies and small chains had the highest cash prices

52 population aged 35-49 years, and distance to pharmacies and was negatively associated with the propor

53 ts were ordered and purchased at an ordinary pharmacy and masked for blinding before the study was st

54 papers were included, representing nursing, pharmacy and medicine from UK, Norway and USA.

55 odes were available only to the MGH Research Pharmacy and not to study investigators or participants.

56 Pharmacy and pathology records of patients dispensed CHB

57 To assist practitioners of medicine and pharmacy and researchers to run most routines in fundame

58 ol in New York City, Philadelphia College of Pharmacy and Science (now University of the Sciences) (B

59 supplements containing selenium bought in a pharmacy and supermarket.

60 ology, critical care, surgery, epidemiology, pharmacy, and adult and pediatric infectious diseases sp

61 ongitudinal population-wide Swedish medical, pharmacy, and criminal registries to evaluate whether ra

62 t psychiatry, transplant infectious disease, pharmacy, and endocrinology were consulted to discuss as

63 cted per-patient cost savings (microbiology, pharmacy, and indirect hospital costs) with the routine

64 tut fur Interdisziplinare Medizin), Burman's Pharmacy, and Kaiser Permanente Southern California.

65 Individual clinical, pharmacy, and laboratory data were merged using individu

66 , we used longitudinally linked demographic, pharmacy, and laboratory databases to examine correlates

67 I have been in schools of natural science, pharmacy, and medicine and have worked in multiple basic

68 nge of applications including biotechnology, pharmacy, and medicine.

69 Hospital, pharmacy, and mortality records between 1995 and 2015 we

70 red micromaterials in soft matter, medicine, pharmacy, and optics.

71 ed information from the membership, medical, pharmacy, and surgical records from the electronic healt

72 ture contamination in terms of microbiology, pharmacy, and wider indirect hospital impacts.

73 ompany-not the manufacturer, distributor, or pharmacy-and is typically a co-pay, which is a fraction

74 uding the private sector--from workplaces to pharmacies--and with increased national and global inves

75 escription sales of antibiotics at community pharmacies as an important task for tackling antibiotics

76 re and either the New Jersey or Pennsylvania pharmacy assistance program during 1994 to 2005, over 18

77 the annual costs (inpatient, outpatient, and pharmacy) associated with extrahepatic manifestations of

78 scores significantly varied by the school of pharmacy attended.

79 to evaluate the effectiveness of a community pharmacy-based case finding and intervention on cardiova

80 In October 2010, the pharmacy began compounding and filter-sterilizing amino

81 nment including payor, prescriber specialty, pharmacy benefit manager, out-of-pocket cost (copay), cl

82 prices of prescription drugs have focused on pharmacy benefit managers (PBMs), third-party intermedia

83 Pharmacy benefit managers negotiate with drug companies

84 between governmental and third-party payers, pharmacy benefit managers, distributers, manufacturers,

85 aried nearly 3-fold among the top 10 largest pharmacy benefit managers.

86 More aggressive management of pharmacy benefits for targeted oral anticancer medicatio

87 A subgroup of 9,027 with pharmacy benefits included 1,158 (12.8%) tobacco users.

88 The pharmacy benefits subgroup experienced 8,152 admissions.

89 onths of continuous enrolment in medical and pharmacy benefits, and those who used other anticoagulan

90 illing codes were queried in a subgroup with pharmacy benefits.

91 Medicare fee-for-service coverage including pharmacy benefits.

92 ilment data were gathered from French retail pharmacies between 1 March 2012 and 31 December 2016.

93 scens BSIs in patients receiving PN from the pharmacy between January and March 2011.

94 ve cohort study using Medicaid encounter and pharmacy billing data from 29 US states between 1999 and

95 study using Medicaid clinical encounter and pharmacy billing records from 1999 through 2010.

96 parations with applications in the fields of pharmacy, biomarker discovery, and protein biology.

97 ge of antimicrobials was important for their pharmacy careers, and 89% desired more education on appr

98 uppressive medication use was defined as any pharmacy charge for a proton-pump inhibitor or histamine

99 Within LT patients, 60% did not have a pharmacy claim 45 days post-index; by 2 years, this redu

100 the mean age for patients who had at least 1 pharmacy claim for narcotics within 1 month before surge

101 years and 41.1 years for patients without a pharmacy claim.

102 Medical and pharmacy claims data between 2007 and 2012 were analyzed

103 This study uses national pharmacy claims data to describes trends in prescription

104 patients age >/= 18 years from a medical and pharmacy claims database for 14 commercial US health pla

105 abetes mellitus identified through visit and pharmacy claims during the observation period.

106 e, descriptive cohort study using nationwide pharmacy claims linked to electronic medical records fro

107 We examined the medical and pharmacy claims of a 20% sample of Medicare beneficiarie

108 ogen + androgen, as captured from outpatient pharmacy claims over a 4-year period.

109 ge administrative database of US medical and pharmacy claims to identify a cohort of 105 269 patients

110 a (1987-2015) with records from a nationwide pharmacy claims warehouse (2005-2015) to examine prescri

111 rence as the percentage of days "covered" by pharmacy claims.

112 grocery-based, small chain, and independent pharmacies compared with a reference group of large chai

113 grocery-based, small chain, and independent pharmacies compared with those at large chain pharmacies

114 al, a community hospital, and an independent Pharmacy Compounding Accreditation Board-accredited phar

115 d case patients' clinical records, evaluated pharmacy compounding practices, and obtained epidemiolog

116 or aseptic facilities, including compounding pharmacies, continues to impact clinical microbiology la

117 Only some urban Indian pharmacies correctly managed patients with presumed tube

118 Pharmacy costs accounted for 28.4% of total direct medic

119 Continuous medical and pharmacy coverage was required for at least 6 months bef

120 prescribed at discharge were abstracted from pharmacy data and converted into OME.

121 ned via medical record review and electronic pharmacy data at diagnosis and within 6 months after dia

122 ns were submitted for 51 466 patients in the pharmacy data set.

123 d from nationwide inpatient, outpatient, and pharmacy data through 2016 (maximum age 44 years).

124 This pharmacoepidemiology study uses US pharmacy data to compare prescriptions for hydroxychloro

125 cal characteristics, laboratory results, and pharmacy data were extracted from the VA electronic medi

126 mation System database using ICD-9 codes and pharmacy data.

127 telet-ASA) were identified from the national pharmacy database (October 1, 2002 to September 30, 2008

128 ronic search of the Kaiser Permanente Hawaii pharmacy database for Generic Product Identification cod

129 n 33 jurisdictions, and data from a national pharmacy database to estimate PrEP uptake.

130 ram database and the Decision Support System pharmacy database were linked to analyze the association

131 bodies were identified using the Mayo Cancer Pharmacy Database.

132 n dosage was determined according to the NHI pharmacy database.

133 Patients were identified through a pharmacy database.

134 entation in the hospital medical records and pharmacy database.

135 the study period, 45 were identified in the pharmacy database: 62% women, 84% white, and 80% relativ

136 07-14), we linked administrative custody and pharmacy databases with mandatory HIV/AIDS surveillance

137 beta2-agonists) were extracted from 65 Dutch pharmacy databases, representing 3% of the population (5

138 hium exposure (n = 11,317) was assessed from pharmacy databases, serum lithium levels were obtained f

139 sources included electronic medical records, pharmacy databases, state birth records, and prospective

140 individual health professions (ie, nursing, pharmacy, dentistry, and dietetics) and offers suggestio

141 on ounces; P = .001), and 12.6% reduction in pharmacies (difference-in-differences, -0.02 million oun

142 Retail pharmacies dispensed 255291 antibiotics to this cohort i

143 No pharmacy dispensed anti-tuberculosis drugs for either ca

144 Electronic health records and pharmacy dispensing data were reviewed for 90 patients w

145 ioners' records, hospital discharge letters, pharmacy dispensing data, and serum fasting glucose meas

146 We collected clinical data and pharmacy dispensing records on patients taking 8, 12, or

147 n (in-office injection, surgical implant, or pharmacy dispensing) for all testosterone products combi

148 use of 1-12 years' duration, determined from pharmacy dispensings.

149 Most students (84%) considered their pharmacy education regarding antimicrobials useful or ve

150 mmunosorbent assay (ELISA, Wantai Biological Pharmacy Enterprise Co., Ltd., Beijing, China).

151 hylprednisolone acetate were recalled by the pharmacy; examination of unopened vials later revealed f

152 We defined ART initiation as the first pharmacy fill date of a qualifying ART regimen of >/=3 d

153 of Transplant Recipients were linked to IMS pharmacy fills (January 1, 2001 to October 1, 2012) to i

154 We evaluated treatment completion through pharmacy fills and reviewed charts for reasons of non-co

155 Bevacizumab acquired from compounding pharmacies for intravitreal injection may cause infectio

156 ical advice and drug dispensing practices of pharmacies for standardised patients with presumed and c

157 lecturers, and practitioners in medicine and pharmacy for conducting standard data analytics.

158 women do not need to return to the clinic or pharmacy for refills every few months.

159 cted cross-sectional data for 2423 community pharmacies from 221 counties or districts in six provinc

160 th use of sales data for retail and hospital pharmacies from the IMS Health MIDAS database, we review

161 onverting enzyme inhibitors, and statins) in pharmacies gathered from 596 communities in 18 countries

162 e study statistician and the investigational pharmacy had the preset randomisation assignments.

163 methylprednisolone produced by a compounding pharmacy has resulted in >750 infections.

164 ed by Canadian guidelines) through community pharmacies, hospitals, or primary care teams in 23 commu

165 ector hospitals and 36 private sector retail pharmacies in 2010 and 72 public hospitals and 72 retail

166 n 2010 and 72 public hospitals and 72 retail pharmacies in 2012.

167 f antibiotics cross-sectionally at community pharmacies in China in 2017, and longitudinally (2011-17

168 il 1, 2014, and Nov 29, 2015, we sampled 622 pharmacies in Delhi, Mumbai, and Patna.

169 We also assessed 213 community pharmacies in Shaanxi province with a baseline survey in

170 s were distributed to clinics and dispensing pharmacies in Shimane and Hiroshima prefectures.

171 ion of repeated PPI and H2B dispensations at pharmacies in Sweden allowed modeling the time-dependent

172 ich includes approximately 60% of all retail pharmacies in the United States.

173 ich includes approximately 60% of all retail pharmacies in the United States.

174 raben (BP) have been widely used in food and pharmacy industries.

175 edical records of laboratory, diagnosis, and pharmacy information.

176 ption dispensing of antibiotics at community pharmacies is a major driver of antimicrobial resistance

177 , and more rigorous oversight of compounding pharmacies is needed to prevent future outbreaks.

178 price increase, suggesting that clinician or pharmacy level interventions could potentially increase

179 p of community mobilisers at health centres, pharmacies, markets, women's organisations, and at "umug

180 cal care, medicine, respiratory therapy, and pharmacy; mean number of nonsurgical participants/sessio

181 p programs (ASPs) to more efficiently review pharmacy, microbiology, and clinical data.

182 hed literature and the direct observation of pharmacy/microbiology staff.

183 e for preparing the study treatments and the pharmacy monitor at each site.

184 ion medicine was available at 63% of private pharmacies (n=109) and 27% of Karunya (semiprivate) phar

185 ies (n=109) and 27% of Karunya (semiprivate) pharmacies (n=22).

186 July 2014 Prescription Drug Plan Formulary, Pharmacy Network, and Pricing Information Files from the

187 An FDA investigation of the compounding pharmacy noted deviations from standard sterile techniqu

188 ch as medicine (magnetic resonance imaging), pharmacy (nuclear magnetic resonance), particle accelera

189 egration into primary health care (medicine, pharmacy, nursing, and allied health science professions

190 standard-dose vaccines in community-located pharmacies offering both vaccines.

191 Compounding pharmacies often prepare parenteral nutrition (PN) and m

192 lished in the subject areas of pharmacology, pharmacy, oncology, and medicinal chemistry.

193 The study drug was prepared by the pharmacy or an otherwise uninvolved research associate s

194 plant extracts with potential application in pharmacy or food industry.

195 ), and those filled at a specialty vs retail pharmacy (OR, 1.96; 95% CI, 1.66-2.33).

196 ection of an oral HIVST from a health clinic/pharmacy), or (3) standard-of-care HIV testing.

197 Patients sought treatment in pharmacies, or with traditional healers who had differen

198 cantly different, medical ICU (p < 0.01) and pharmacy (p < 0.05) operating costs were significantly l

199 have explored the knowledge and attitude of pharmacy personnel towards guidelines for the management

200 he management of constipation was poor among pharmacy personnel.

201 From a hospital pharmacy perspective, a cost-consequence analysis model

202 ent from a paper in 2000 about critical care pharmacy practice and makes recommendations for future p

203 atabase that is part of the population-based pharmacy prescription InterAction Database from the nort

204 s, outpatient encounters and procedures, and pharmacy prescriptions.

205 ics were obtained by questionnaires and from pharmacy printouts and medical charts.

206 scular Data Registry PINNACLE were linked to pharmacy, private practitioner, and hospital claims data

207 H (Alberta Vascular Risk Reduction Community Pharmacy Project) study was a randomized trial conducted

208 The order in which each pharmacy provided the intervention or control was random

209 a-driven health measure based on 21 years of pharmacy purchase and mortality data of 12,047 aging ind

210 Pharmacy purchasing data underestimated cost savings com

211 or a total yearly cost savings of $54656 for pharmacy purchasing data, $1184336 for EMR data, and $21

212 pectively assessed anti-infective cost using pharmacy purchasing data, patient-level administration d

213 Pharmacy purchasing endorsed minimal financial benefit (

214 ients pick up their medication outside usual pharmacy queues.

215 rapy, surgery, and support services, such as pharmacy, radiology, laboratory, and counselling) at Hop

216 Four national chain pharmacies received surveys requesting price data on com

217 s defined according to hospital diagnosis or pharmacy records (two or more prescriptions for ADHD dru

218 information was ascertained from electronic pharmacy records and analyzed using conditional logistic

219 h 1, 2013, and July 15, 2015, via electronic pharmacy records and departmental databases at three ins

220 ntinuously for at least 5 years according to pharmacy records and who were evaluated with visual fiel

221 cteristics from hospitalization records, and pharmacy records as covariates, we controlled for confou

222 reviewing filled prescriptions in electronic pharmacy records during a 10-year period before the Barr

223 ormation on medication use was compared with pharmacy records for statins, calcium channel blockers,

224 sic prescription rates were much higher than pharmacy records indicate, with self-reported prescribin

225 zed trials, and multiple recent studies with pharmacy records indicates that the delivery of OMT is f

226 tion period were ascertained by linkage with pharmacy records through the national health insurance s

227 Detailed electronic medical and pharmacy records were analyzed to explore the associatio

228 integrated national US transplant registry, pharmacy records, and Medicare claims data for 16 308 ki

229 Compared with pharmacy records, self-reported information on current m

230 Compared with pharmacy records, the sensitivity, specificity, and PPV

231 etes medications as captured from outpatient pharmacy records.

232 on information were collected by medical and pharmacy records.

233 was defined using public medical, legal, or pharmacy records.

234 of vaccination were collected by medical and pharmacy records.

235 encephalopathy (HE) and reviewed medical and pharmacy records.

236 (MPR, a validated adherence metric based on pharmacy refill data) over the past 3 months and loss to

237 cohol use disorder in medical, criminal, and pharmacy registries was assessed in a population-based S

238 pulation-wide Swedish medical, criminal, and pharmacy registries were used to evaluate the risk of de

239 use was assessed from medical, criminal, and pharmacy registries.

240 UD was assessed using medical, criminal, and pharmacy registries.

241 der was assessed from medical, criminal, and pharmacy registries.

242 use disorder recorded in medical, legal, or pharmacy registry records.

243 Drug abuse recorded in medical, legal, or pharmacy registry records.

244 mpling for bacteria and fungi in compounding pharmacies require the use of a medium for each type of

245 Patients were most often referred to pharmacies/retail stores and public health departments.

246 r (May 1 to July 30, 2013) the Ohio Board of Pharmacy's requirement of PSPs for bevacizumab.

247 ; 95% confidence interval, 1.01-1.03) higher pharmacy sales rate from 2005 through 2009, although thi

248 the IMS Health National Prescription Audit (pharmacy sales), and the MarketScan Commercial Claims da

249 escriptions for advertised products based on pharmacy sales; (2) prescription claims for asthma medic

250 predictors of a higher knowledge score were pharmacy school attended, planned postgraduate training,

251 tation in infectious diseases, perception of pharmacy school education as useful, use of resources to

252 ndertook two public (hospitals) and private (pharmacy) sector surveys of prices and availability of m

253 Expansion of clinical pharmacy services is often impeded by policy, legislatio

254 a critical care pharmacist and the scope of pharmacy services within the ICU.

255 alyses, highlighting the benefit of clinical pharmacy services, are summarized.

256 Seventy-one hospitals (76%) had any pharmacy services.

257 t outpatients; and radiology, pathology, and pharmacy services.

258 ating to critical care pharmacist duties and pharmacy services.

259 ating to critical care pharmacist duties and pharmacy services.

260 lion vaccinated beneficiaries in a community pharmacy setting.

261 edicine screening program in urban clinic or pharmacy settings in the United States serving predomina

262 INSIGHT]) was conducted at 4 urban clinic or pharmacy settings in the United States serving predomina

263 ma control, or speak with an asthma nurse or pharmacy staff member.

264 Participants, physicians, and pharmacy staff were masked to group assignment.

265 rapid organism identification and dedicating pharmacy stewardship personnel time on the total hospita

266 of implementing MALDI-TOF and of dedicating pharmacy stewardship personnel time to interventions, th

267 Pharmacy stockouts could not be calculated at this site.

268 the desired target for on-time pill pickup, pharmacy stockouts, and virological suppression.

269 Across 16 325 ZIP codes, 68 353 unique pharmacy stores contributed cash prices.

270 nd resistance was administered to graduating pharmacy students at 12 US schools of pharmacy.

271 Pharmacy students perceive antimicrobial stewardship to

272 Of 1445 pharmacy students, 579 (40%) completed the survey.

273 ear P2Y(12) inhibitor persistence (no gap in pharmacy supply >30 days) and major adverse cardiovascul

274 rvey was conducted among 201 pharmacists and pharmacy technicians from an existing panel.

275 walk-in clinics located in retail stores or pharmacies that are typically staffed by nurse practitio

276 nactivated influenza vaccines from community pharmacies that offered both vaccines during the 2012-13

277 Among the 75 pharmacies that stocked cessation medications, 96% had n

278 ributers, manufacturers, health systems, and pharmacies that together mediate the receipt of goods by

279 eport by the FDA based on site visits to the pharmacy that prepared the bevacizumab syringes was summ

280 st cash prices for generic drugs and big box pharmacies the lowest.

281 ing invalid interactions within 12 community pharmacies, the study included 4822 simulated interactio

282 must assure that services such as radiology, pharmacy, the laboratory, and information services are p

283 ric cases (from 154 [72.3%] of 213 community pharmacies to 107 [50.2%], p<0.0001) and adult cases (fr

284 Using pharmacy transaction data, we evaluated 45029 patients w

285 ystems for medication provision in community pharmacies; triage processes to enable effective and tim

286 ity and subgroup analyses by insurance type, pharmacy type, sex, and indication identified similar as

287 ption dispensing of antibiotics at community pharmacies was still prevalent nationwide in China in 20

288 S. marcescens was identified from a pharmacy water faucet, mixing container, and opened amin

289 harmacies compared with those at large chain pharmacies were 0.52 (95% CI, 0.51 to 0.53), 0.82 (CI, 0

290 on all drugs dispensed from community-based pharmacies were assembled.

291 Studies set in retail pharmacies were excluded.

292 ons of bevacizumab acquired from compounding pharmacies were negative for microbial contaminants and

293 upermarkets, 20 mass merchandise stores, 217 pharmacies) were analyzed.

294 rmy career, criminal justice, and medical or pharmacy) were used to predict suicides in the subsequen

295 ector, private-sector facilities, especially pharmacies, were not widely accessed for tuberculosis di

296 available if they were present in the local pharmacy when surveyed, and affordable if their combined

297 were considered available if present at the pharmacy when surveyed, and affordable if their combined

298 In 3 of 10 compounding pharmacies where more than 1 sample was available, there

299 on seems to have occurred at the compounding pharmacy, where numerous problems in sterile technique w

300 tts General Hospital (MGH) Clinical Research Pharmacy with a permuted-block algorithm, stratified by